Skip to main content

Table 1 Association between each covariate and the end point using chi-squared tests, along with the test p-value, counts and proportions with respect to the end point

From: Real-world evidence with a retrospective cohort of 15,968 COVID-19 hospitalized patients suggests 21 new effective treatments

covariate

survival

death

p-value

Total N

13,116

2678

 

Sex (female)

6024 (45.9)

1129 (42.2)

< 0.001

Flu vaccine

5465 (41.7)

1746 (65.2)

< 0.001

Pneumococcal vaccine

3441 (26.2)

1111 (41.5)

< 0.001

Diabetes

3856 (29.4)

1167 (43.6)

< 0.001

Circulatory diseases

8111 (61.8)

2261 (84.4)

< 0.001

Cancer

1550 (11.8)

545 (20.4)

< 0.001

Respiratory diseases

2896 (22.1)

828 (30.9)

< 0.001

Dementia

964 (7.3)

536 (20.0)

< 0.001

Other mental diseases

1764 (13.4)

407 (15.2)

0.018

Anxiety and mood disorders

3382 (25.8)

784 (29.3)

< 0.001

Age

  

< 0.001

 18–40

1399 (10.7)

20 (0.7)

 

 41–67

5971 (45.5)

380 (14.2)

 

 68–99

5746 (43.8)

2278 (85.1)